1. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study. Issue 5 (5th February 2021) Authors: Yu, Yuman; Wang, Yuehong; Wu, Linying; Xu, Xuanli; Zhou, Hua; Wang, Qing; Zhou, Jianying Other Names: Mao. Chao section editor. Journal: Medicine Issue: Volume 100:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Physiologically based pharmacokinetic (PBPK) modeling of BDE-209 following oral exposure in Chinese population. (November 2022) Authors: Zhang, Zhichun; Hu, Man; Xuan, Dongliang; Wu, Linying; Zhang, Yanfei; He, Gengsheng; Zhou, Ying Journal: Food and chemical toxicology Issue: Volume 169(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer. (1st November 2018) Authors: Wang, Yuehong; Wu, Linying; Yao, Yinan; Lu, Guohua; Xu, Liming; Zhou, Jianying Journal: Cancer letters Issue: Volume 436(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Untargeted metabolomics allows to discriminate raw camel milk, heated camel milk, and camel milk powder. (January 2022) Authors: Li, Rongrong; Wang, Shuang; Zhang, Jiawei; Miao, Jing; Chen, Gangliang; Dong, Jing; Wu, Linying; Yue, Haitao; Yang, Jie Journal: International dairy journal Issue: Volume 124(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗